EMN
Live chart
What they do
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables.
For information only · Important disclosures
Grades vs sector
Momentum50th percentile in sectorC+
Percentile within its GICS sector across the S&P 1500.
Growth54th percentile in sectorC+
Percentile within its GICS sector across the S&P 1500.
Value78th percentile in sectorB+
Percentile within its GICS sector across the S&P 1500.
Profitability40th percentile in sectorC
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Discounted cash flow
Starting cash flow is mid-cycle: 8.5% average margin × current revenue = 0.8B (last 12 months: 0.5B at a 6% margin). On trailing cash flow the base case would be $27.
Edit assumptions · recalculates instantly
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.08 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Materials
cheaper
cheaper
cheaper
cheaper
cheaper
cheaper
Forward EPS $6.64 vs trailing $3.83 (+73% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Piotroski F-score 5/9 · last two fiscal years
Altman Z-score 2.4 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $8.8B | $474.0M | $424.0M |
| 2024 | $9.4B | $905.0M | $688.0M |
| 2023 | $9.2B | $894.0M | $546.0M |
| 2022 | $10.6B | $793.0M | $364.0M |
| 2021 | $10.5B | $857.0M | $1.1B |
| 2020 | $8.5B | $478.0M | $1.1B |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -6.1%.
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | 1.82 | 1.97 | +8.2% |
| 2026-04-30 | 1.06 | 1.09 | +2.4% |
| 2026-01-29 | 0.72 | 0.75 | +4.2% |
| 2025-11-03 | 1.17 | 1.14 | -2.2% |
| 2025-07-31 | 1.75 | 1.60 | -8.7% |
| 2025-04-24 | 1.89 | 1.91 | +1.2% |
| 2025-01-30 | 1.57 | 1.87 | +18.9% |
| 2024-10-31 | 2.14 | 2.26 | +5.4% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-03-31 | $2.2B | -4.9% |
| 2025-12-31 | $2.0B | – |
| 2025-09-30 | $2.2B | – |
| 2025-06-30 | $2.3B | – |
| 2025-03-31 | $2.3B | – |
Rating changes
Third-party analyst actions, not Coteau's views. All rating changes
Recent dividends
Insider trades
$234.1K
–
–
–
–
–
–
–
–
–
–
–
Stats refreshed 2026-10-21 18:07:21 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Beta 0.9 · Oct 21, 2026